Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484730 · ClinicalTrials.gov registry record
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
A clinical trial of Abnormal Vascular Flow, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT01484730 is a study of Abnormal Vascular Flow that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01484730, a study of Abnormal Vascular Flow, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic feasibility of the imaging instruments.
Conditions Studied
Interventions
- DEVICE Multi-Spectral and Laser Speckle Imaging
Study Locations (1)
California
- Beckman Laser Institute and Medical Clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-11 |
| Est. Completion | 2028-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484730
The ClinicalTrials.gov registry entry for NCT01484730 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abnormal Vascular Flow appearing as the primary indexed condition, and to 1 intervention - of which Multi-Spectral and Laser Speckle Imaging is the first listed.
NCT01484730 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01484730 about?
NCT01484730 is a clinical study titled "A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion". The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic ...
What is the current status of trial NCT01484730?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2011-11. Estimated completion is 2028-08.
What conditions does trial NCT01484730 study?
This clinical trial studies the following conditions: Abnormal Vascular Flow.
What interventions are being tested in trial NCT01484730?
The interventions under investigation include: Multi-Spectral and Laser Speckle Imaging (DEVICE).
Who is sponsoring clinical trial NCT01484730?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01484730 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.